| Drug Name | Active Ingredient(s) | Strength | Form/Route | Marketing Status | RLD | TE Code |
|---|---|---|---|---|---|---|
| ERBITUX | CETUXIMAB | 100mg/VIAL | VIAL; INTRAVENOUS | 1 | 0 |
| Date | Supplement No. | Action | Documents |
|---|---|---|---|
| Mar 04, 2013 | 242 | Labeling Revision | |
| Jul 06, 2012 | 225 | Supplement | |
| Jan 24, 2012 | 228 | Supplement | |
| Jan 19, 2012 | 229 | Supplement | |
| Oct 02, 2007 | 103 | Supplement | |
| Nov 07, 2011 | 153 | Supplement | |
| Sep 01, 2005 | 0030 | Supplement | |
| Jul 22, 2009 | 0167 | Supplement | |
| Jul 17, 2009 | 168 | Supplement | |
| Sep 12, 2008 | 139 | Supplement | |
| Mar 01, 2006 | 0076 | Supplement | |
| Mar 01, 2006 | 0046 | Supplement | |
| Feb 12, 2004 | 000 | Approval | |
| Jun 18, 2004 | 0001 | Supplement |